
Layla D. Berry
Examiner (ID: 310, Phone: (571)272-9572 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1623, 1609, 1693, 1673 |
| Total Applications | 1764 |
| Issued Applications | 1125 |
| Pending Applications | 103 |
| Abandoned Applications | 569 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19003602
[patent_doc_number] => 20240067673
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-29
[patent_title] => MODIFIED NUCLEOSIDE OR NUCLEOTIDE
[patent_app_type] => utility
[patent_app_number] => 18/033037
[patent_app_country] => US
[patent_app_date] => 2021-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27156
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 1377
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18033037
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/033037 | MODIFIED NUCLEOSIDE OR NUCLEOTIDE | Oct 20, 2021 | Pending |
Array
(
[id] => 17385677
[patent_doc_number] => 20220033529
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => REGENERATED CELLULOSIC FIBRES SPUN FROM AN AQUEOUS ALKALINE SPINDOPE
[patent_app_type] => utility
[patent_app_number] => 17/503758
[patent_app_country] => US
[patent_app_date] => 2021-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6518
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17503758
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/503758 | REGENERATED CELLULOSIC FIBRES SPUN FROM AN AQUEOUS ALKALINE SPINDOPE | Oct 17, 2021 | Abandoned |
Array
(
[id] => 20239594
[patent_doc_number] => 12419898
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-23
[patent_title] => Synergistic composition for maintenance of healthy balance of microflora
[patent_app_type] => utility
[patent_app_number] => 17/496814
[patent_app_country] => US
[patent_app_date] => 2021-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3372
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17496814
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/496814 | Synergistic composition for maintenance of healthy balance of microflora | Oct 7, 2021 | Issued |
Array
(
[id] => 17385576
[patent_doc_number] => 20220033428
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => LARGE SCALE PREPARATION OF PSEUDO-TRISACCHARIDE AMINOGLYCOSIDES AND OF INTERMEDIATES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/493672
[patent_app_country] => US
[patent_app_date] => 2021-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24249
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17493672
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/493672 | LARGE SCALE PREPARATION OF PSEUDO-TRISACCHARIDE AMINOGLYCOSIDES AND OF INTERMEDIATES THEREOF | Oct 3, 2021 | Abandoned |
Array
(
[id] => 20621616
[patent_doc_number] => 12589110
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-31
[patent_title] => Carbonated aerosol external preparation for skin
[patent_app_type] => utility
[patent_app_number] => 18/247598
[patent_app_country] => US
[patent_app_date] => 2021-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2035
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18247598
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/247598 | Carbonated aerosol external preparation for skin | Sep 30, 2021 | Issued |
Array
(
[id] => 18784836
[patent_doc_number] => 20230372492
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-23
[patent_title] => DRUGS CONJUGATED WITH HEXOSE PHOSPHATE AND METHODS OF MAKING AND USING SAME
[patent_app_type] => utility
[patent_app_number] => 18/247049
[patent_app_country] => US
[patent_app_date] => 2021-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6563
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18247049
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/247049 | DRUGS CONJUGATED WITH HEXOSE PHOSPHATE AND METHODS OF MAKING AND USING SAME | Sep 28, 2021 | Pending |
Array
(
[id] => 19150126
[patent_doc_number] => 11975016
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-07
[patent_title] => 2'-substituted-N
[patent_app_type] => utility
[patent_app_number] => 17/482224
[patent_app_country] => US
[patent_app_date] => 2021-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34801
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17482224
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/482224 | 2'-substituted-N | Sep 21, 2021 | Issued |
Array
(
[id] => 18724145
[patent_doc_number] => 20230338265
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => NOVEL USE OF SACCHARIDE ISOMERATE
[patent_app_type] => utility
[patent_app_number] => 18/025380
[patent_app_country] => US
[patent_app_date] => 2021-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7602
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18025380
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/025380 | NOVEL USE OF SACCHARIDE ISOMERATE | Sep 9, 2021 | Pending |
Array
(
[id] => 17704957
[patent_doc_number] => 20220204963
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => OLIGOSACCHARIDES COMPRISING AN AMINOOXY GROUP AND CONJUGATES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/472367
[patent_app_country] => US
[patent_app_date] => 2021-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9478
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17472367
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/472367 | OLIGOSACCHARIDES COMPRISING AN AMINOOXY GROUP AND CONJUGATES THEREOF | Sep 9, 2021 | Abandoned |
Array
(
[id] => 20911803
[patent_doc_number] => 12708638
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-08-18
[patent_title] => Semicarbazone-based saponin conjugate
[patent_app_type] => utility
[patent_app_number] => 18/044950
[patent_app_country] => US
[patent_app_date] => 2021-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 77
[patent_figures_cnt] => 41
[patent_no_of_words] => 44987
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 265
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18044950
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/044950 | SEMICARBAZONE-BASED SAPONIN CONJUGATE | Sep 8, 2021 | Pending |
Array
(
[id] => 18675287
[patent_doc_number] => 20230312887
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => PROCESS FOR PREPARING SUGAMMADEX
[patent_app_type] => utility
[patent_app_number] => 18/022570
[patent_app_country] => US
[patent_app_date] => 2021-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10727
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18022570
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/022570 | PROCESS FOR PREPARING SUGAMMADEX | Sep 7, 2021 | Pending |
Array
(
[id] => 17312824
[patent_doc_number] => 20210401872
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => HyperOsmolar Composition of Hyaluronic Acid
[patent_app_type] => utility
[patent_app_number] => 17/467918
[patent_app_country] => US
[patent_app_date] => 2021-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2987
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17467918
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/467918 | Hyperosmolar composition of hyaluronic acid | Sep 6, 2021 | Issued |
Array
(
[id] => 17563152
[patent_doc_number] => 20220127301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => ASYMMETRIC AUXILIARY GROUP
[patent_app_type] => utility
[patent_app_number] => 17/465238
[patent_app_country] => US
[patent_app_date] => 2021-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14251
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17465238
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/465238 | Asymmetric auxiliary group | Sep 1, 2021 | Issued |
Array
(
[id] => 19032467
[patent_doc_number] => 20240082282
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => Hygromycin A Compositions and Methods of Use
[patent_app_type] => utility
[patent_app_number] => 18/042741
[patent_app_country] => US
[patent_app_date] => 2021-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22523
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18042741
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/042741 | Hygromycin A Compositions and Methods of Use | Aug 31, 2021 | Abandoned |
Array
(
[id] => 18716556
[patent_doc_number] => 11793879
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-24
[patent_title] => Monolithic composition for dual-rate release with high drug loading
[patent_app_type] => utility
[patent_app_number] => 17/405610
[patent_app_country] => US
[patent_app_date] => 2021-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5682
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17405610
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/405610 | Monolithic composition for dual-rate release with high drug loading | Aug 17, 2021 | Issued |
Array
(
[id] => 17460611
[patent_doc_number] => 20220073916
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-10
[patent_title] => NOVEL PHOSPHORAMIDITES
[patent_app_type] => utility
[patent_app_number] => 17/405708
[patent_app_country] => US
[patent_app_date] => 2021-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23089
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17405708
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/405708 | NOVEL PHOSPHORAMIDITES | Aug 17, 2021 | Pending |
Array
(
[id] => 17314453
[patent_doc_number] => 20210403501
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => COMPOSITIONS AND METHODS OF MODULATING THE IMMUNE RESPONSE BY ACTIVATING ALPHA PROTEIN KINASE 1
[patent_app_type] => utility
[patent_app_number] => 17/445113
[patent_app_country] => US
[patent_app_date] => 2021-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42494
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17445113
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/445113 | Compositions and methods of modulating the immune response by activating alpha protein kinase 1 | Aug 15, 2021 | Issued |
Array
(
[id] => 18825281
[patent_doc_number] => 11840551
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-12
[patent_title] => Compositions and methods of modulating the immune response by activating alpha protein kinase 1
[patent_app_type] => utility
[patent_app_number] => 17/445122
[patent_app_country] => US
[patent_app_date] => 2021-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 57
[patent_no_of_words] => 42545
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17445122
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/445122 | Compositions and methods of modulating the immune response by activating alpha protein kinase 1 | Aug 15, 2021 | Issued |
Array
(
[id] => 17383845
[patent_doc_number] => 20220031697
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => Dose and regimen for an hdm2-p53 interaction inhibitor in hematological tumors
[patent_app_type] => utility
[patent_app_number] => 17/401600
[patent_app_country] => US
[patent_app_date] => 2021-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6809
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17401600
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/401600 | Dose and regimen for an hdm2-p53 interaction inhibitor in hematological tumors | Aug 12, 2021 | Abandoned |
Array
(
[id] => 18753952
[patent_doc_number] => 20230357303
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => HYBRID AMIDE DERIVATIVES OF AMPHOTERICIN B
[patent_app_type] => utility
[patent_app_number] => 18/020119
[patent_app_country] => US
[patent_app_date] => 2021-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18064
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18020119
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/020119 | Hybrid amide derivatives of amphotericin B | Aug 8, 2021 | Issued |